The CC chemokine regulated upon activation, normal T-cell exsome 17q (5, 6) , where the gene encoding RANTES is located, the RANTES promoter region (7, 9), whereas another ge-83 middle-onset patients with asthma (onset at 20 to 40 years of netic study found a significant association of the Ϫ403A allele age), and 98 early-onset patients with asthma (onset at less than with atopy and asthma in adults (10). 20 years of age). The Ϫ28G allele was significantly associated with late-onset asthma (odds ratio ϭ 2.033; 95% confidence interval,
previous study, we found that the age at onset of asthma (SNP) affects alteration of total serum IgE levels by the FCER1B Regulated upon activation, normal T-cell expressed and sepromoter polymorphism (14) . Although the characteristic creted (RANTES) is a CC chemokine that has been shown features of the histopathology of asthma generally include to be a potent chemoattractant for T cells, eosinophils, basopersistent airway inflammation and tissue eosinophilia, asthma phils, monocyte/macrophages, and mast cells (1) . Both atopic is a heterogeneous condition with a number of overlapping asthma and nonatopic asthma are associated with increased phenotypes, typified at the extremes by early-onset asthma levels of RANTES in bronchoalveolar lavage fluid (2) and (in which atopy is a prominent feature) and late-onset asthma bronchial mucosal expression of RANTES (together with (in which atopy is often not present). Interactions of environeosinophil-active cytokines such as interleukin-5, granulocyte mental factors with specific genes may influence clinical premacrophage colony-stimulating factor, and interleukin-3), sentation of asthma, including the clinical course (early onset which contributes to the bronchial mucosal accumulation of or late onset), the severity of the disease, and therapeutic activated eosinophils (3) . The potential role of RANTES in responses. We hypothesized that two functional alleles at the asthma is also supported by observations that many cell types RANTES promoter region influence susceptibility to asthma present in asthmatic airways, such as T cells, platelets, macroand that genetic manifestations of these alleles may be conphages, endothelial cells, fibroblasts, epithelial cells, and mast founded by the age at the onset of asthma. Using case-control cells, have the capacity to generate RANTES (4) .
analysis, we evaluated the association of these two functional Previous linkage studies have found that human chromopolymorphisms with asthma, dividing subjects into three subgroups according to the age at onset (early, middle, and late onset).
(Received in original form February 8, 2002 ; accepted in final form June 14, 2002) 
METHODS
Supported in part by a Grant-in-Aid for Scientific Research 13,670,585 from the Japan Society for the Promotion of Science
Study Population
Correspondence and requests for reprints should be addressed to Nobuyuki Hi-
The study was comprised of 298 patients with asthma and 311 healthy zawa, First Department of Medicine, Hokkaido University School of Medicine, Kitacontrol subjects. Total serum IgE levels (IU/ml) and specific IgE reKu, N-15 N-7, Sapporo, Japan 060-8638. E-mail: nhizawa@med.hokudai.ac.jp
sponses to 10 common inhaled allergens, including Dermatophagoides
This article has an online data supplement, which is accessible from this issue's farinae, grass pollens, animal dander, and molds, were determined. We allergens. All participants (n ϭ 609) were Japanese, and all gave written informed consent for enrollment in the study and all associated proce- dures. The ethics committee of the School of Medicine, Hokkaido phism with late-onset asthma, further analyses were limited to the 117 University, approved the study.
patients with late-onset asthma and the 311 control subjects. To evaluate association of the Ϫ403G/A and Ϫ28C/G polymorphisms with lateAllele-Specific Polymerase Chain Reaction and Detection of onset asthma in the context of haplotype, we assessed differences in Fluorescence-labeled Polymerase Chain Reaction Fragments haplotype distributions using the log-likelihood ratio test (16) .
To control for potential confounding effects of the Ϫ403G/A genoUsing kinetic thermal cycling (15), we determined the genotypes of all types, chi-square analysis was performed using the Mantel-Haenszel 609 subjects with respect to two RANTES promoter polymorphisms:
test and stratification according to Ϫ403G/A genotype. Also, using Ϫ28C/G and Ϫ403G/A. Genotyping was performed by allele-specific multiple regression, we adjusted measurements for possible confoundpolymerase chain reaction; incorporation of SYBR Green I (Applied ing effects of the Ϫ403G/A genotypes, age, sex, smoking status (never Biosystems, Foster City, CA) into the real-time polymerase chain reacsmoked, ex-smoker, or current smoker), and atopic status on the odds tion allowed discrimination between specific and nonspecific products.
ratios for the Ϫ28C/G polymorphism.
To examine further the relationship between the age at onset of Quantitation of RANTES Protein Levels asthma and genetic effects of the Ϫ28G allele, we performed survival Using enzyme-linked immunosorbent assay, we measured RANTES analyses with the age at onset of asthma as the primary outcome, using protein levels in supernatants of phytohemagglutinin (PHA)-stimulated all subjects (patients with asthma and control subjects, n ϭ 609) or mononuclear cells taken from 70 healthy subjects.
using only patients with asthma (n ϭ 298). The subgroups stratified according to the RANTES Ϫ28C/G genotypes were analyzed for time Statistical Analysis to the development of asthma using the standard Kaplan-Meier method. We divided patients with asthma into three subgroups according to the We compared RANTES protein production of mononuclear cells in age at onset (Group 1, 0-19 years; Group 2, 20-40 years; and Group response to PHA stimulation between the Ϫ403G/A genotypes (Ϫ403A 3, 41 years or more). The chi-square test was used to compare qualitative carriers versus noncarriers) and between the Ϫ28C/G genotypes (Ϫ28G risk factors (sex, smoking status, and atopic status) among the three carriers versus non-carriers), using an unpaired t test. subgroups and the controls. One-way analysis of variance was used to compare quantitative risk factors (age and serum IgE levels). We tested
RESULTS
agreement with Hardy-Weinberg equilibrium using a goodness-fit chisquare test.
Patients with early-onset asthma were highly atopic as a populaUnivariate logistic regression analysis was initially used to calculate tion, compared with patients with late-onset asthma and healthy odds ratios with 95% confidence intervals as estimates of relative risk controls (Table 1) . Of the three asthma subgroups, patients with for development of asthma (early, middle, and late onset). As results of case-control analysis indicated association of the Ϫ28C/G polymorlate-onset asthma had the lowest levels of mean total serum IgE, * Multivariate analysis for odds of late-onset asthma was performed by logistic were estimated under the hypothesis of association between two RANTES proregression, with atopy and the RANTES promoter genotypes coded according to moter polymorphisms and late-onset asthma using the EH program (16) . The the presence or absence of the Ϫ403A or Ϫ28G alleles. In addition to atopy and strongest association is between late-onset asthma and the haplotype comprising the two polymorphisms, sex, age, and smoking status were also adjusted in the both the Ϫ403G and Ϫ28G alleles. multivariate logistic regression model.
the lowest frequency of atopic individuals, and the lowest levels for the development of late-onset asthma (adjusted odds ratio ϭ of mean FEV 1 /FVC. In addition, the frequency of ex-smokers 3.88; 95% confidence interval, 1.74, 8.64; p ϭ 0.000926; Table 4 ). was highest in the late-onset asthma group (Table 1) , and cumuTaken together, these results strongly suggest that the genetic lative tobacco exposure before the onset of asthma was highest effect of the Ϫ28G allele contributes to the development of lateamong patients with late-onset asthma. Four early-onset, 33 midonset asthma, which is independent of atopy and the genetic dle-onset, and 41 late-onset patients with asthma were exposed effect of the Ϫ403A allele. to tobacco smoke before the onset of asthma; mean Ϯ SD of Figure E3 in the online supplement shows the plots of the log (cigarettes ϫ years) for these smokers was 1.79 Ϯ 0.54, estimates of the log cumulative hazard for the development of 2.25 Ϯ 0.37, and 2.78 Ϯ 0.39, respectively (p Ͻ 0.0001, analysis asthma. In each group of subjects ( Figures E3A and E3B) , the of variance).
curves for the groups are parallel until the age of 40 years; the The allelic frequencies and distribution of genotypes among slope of the log cumulative hazard plot of the Ϫ28G carrier the healthy control subjects (Ϫ403A frequency, 0.670; Ϫ28G, becomes steeper after the age of 40 years. Although none of the 0.881) were similar to those reported for control subjects in a statistical tests are effective at detecting this kind of difference previous study (8) of Japanese subjects (Ϫ403A, 0.624; Ϫ28G, between two groups, a visual comparison of the estimated sur-0.860). Both polymorphisms fulfilled Hardy-Weinberg expectavival curves supported our finding that there is a significant tions for these control subjects.
association between late-onset asthma and the RANTES-28G We found that the Ϫ28C/G promoter polymorphism is sigallele. nificantly associated with late-onset asthma (odds ratio ϭ 2.033;
Mononuclear cells from control subjects who carried the 95% confidence interval, 1.379-2.998; p ϭ 0.000341). In contrast, Ϫ28G allele (n ϭ 20) produced significantly greater levels of there were no significant differences in genotype distribution of RANTES protein than cells from controls who did not carry the Ϫ28C/G promoter polymorphism between healthy control this allele (n ϭ 50): 9,440 Ϯ 565 (mean Ϯ SD) versus 7,978 Ϯ subjects and patients with early-or middle-onset asthma (Table  358 pg/ml (p ϭ 0.012; Figure 1 ). In contrast, mean concentrations 2). Also, in none of the asthma subgroups was the Ϫ403G/A of RANTES protein did not differ between Ϫ403G/A genotypes promoter polymorphism associated with development of asthma ( Figure 1 ). (Table 2 ). Because we initially studied two markers (Ϫ403G/A and Ϫ28C/G polymorphisms) in three asthma subgroups (early, DISCUSSION middle, and late onset), we multiplied our significance levels by six (two markers ϫ three subgroups). Using this stringent This case-control study provides evidence indicating that the correction, the association between Ϫ28C/G polymorphism and Ϫ28C/G polymorphism in the RANTES gene is associated with late-onset asthma had a (corrected) p value of less than 0.0025.
The Ϫ403G/A and Ϫ28C/G polymorphisms were in a significant linkage disequilibrium, with the Ϫ403G allele strongly associated with the Ϫ28C allele (p Ͻ 0.001). The frequencies of twolocus haplotypes of the Ϫ403G/A and Ϫ28C/G polymorphisms differed significantly between patients with late-onset asthma and control subjects (p ϭ 0.00136, log-likelihood test; Table 3 ). This finding is consistent with the single-locus data and supports the association of late-onset asthma with the Ϫ28C/G polymorphism within the haplotype context.
The Mantel-Haenszel test, stratified by the Ϫ403G/A genotype, showed a significant association between the Ϫ28C/G genotype and the development of late-onset asthma (Mantel-Haenszel chi-square ϭ 10.41 with three degrees of freedom, p ϭ 0.00125). In addition, the relative risk of asthma for the Ϫ28G carriers did not change after adjustment for potential confound- that the presence of the Ϫ28G allele was a significant risk factor susceptibility to development of late-onset asthma in Japanese. may suggest hereditary propensity for overexpression of the RANTES gene in response to a wider variety of inhaled stimuli. The association that we observed between the Ϫ28C/G polymorphism and RANTES protein levels in vitro supports the hypotheViral infections induce a number of cytokine mediators, including RANTES, in both local macrophage populations and sis that this specific locus is involved in development of lateonset asthma. Four binding sites for nuclear factor-B in the airway epithelial cells (29) . These mediators upregulate airway inflammation and increase airway responsiveness. Indeed, there RANTES promoter are critical for induction by the proinflammatory cytokines tumor necrosis factor-␣ and interleukin-1␤ and is the possibility of a pathogenic link between asthma and viral infection (30) . Therefore, in individuals possessing the poteninduction through the CD28 costimulatory pathway (17) . The Ϫ28C/G polymorphism is located immediately downstream of tially functional Ϫ28G allele, RANTES may be expressed to a greater extent in response to exogenous stimuli, including viral the first of these nuclear factor-B binding sites (Ϫ40 to Ϫ31). However, as with any genetic association, it is theoretically possiantigens, leading to exaggerated inflammation in the airways. Given the relatively small differences in induced luciferase activble that the Ϫ28C/G polymorphism is merely in linkage disequilibrium with alleles that cause the effects that we observed.
ity previously observed for different alleles of the Ϫ28C/G polymorphism (8), prolonged and repeated exposure to exogenous Although the Ϫ403G/A polymorphism did not appear to influence risk of asthma in these subjects, it is associated with atopic stimuli may be required for the Ϫ28G allele to manifest genetic effects in airways, which may in part explain why this allele is dermatitis (7) in African Americans and with atopy and asthma in white individuals (10) . This suggests that phenotypic effects of associated with late-onset asthma but not early-or middle-onset asthma. the Ϫ403G/A and Ϫ28C/G polymorphisms and their interaction may vary according to environmental and genetic backgrounds, Specific chemokines are involved in different cellular and molecular pathways that contribute to the complex pathophysiolresulting in a complex system of RANTES regulation in humans.
These findings indicate that genetic manifestations of the ogy of asthma in a coordinated fashion, and the role of RANTES in asthma pathogenesis is also known to be extremely complex Ϫ28G allele of the RANTES promoter vary with the age at onset of asthma. The correlation between genetic heterogeneity (31) . It is, therefore, necessary to be cautious about the clinical implications of these results until the effects of the Ϫ28G allele and age at onset is evident in several complex diseases, including Alzheimer's disease (18), breast cancer (19) , and Parkinson disin vivo are understood in greater detail. It is also important to note that the case-control approach has an inherent potential for ease (20) . Genetic effects of the Ϫ28G allele of the RANTES promoter may be causative factors of late-onset asthma. Alfalse-positive results caused by population stratification. Familybased association studies that include the transmission disequithough bronchial asthma is caused by complex interactions among genetic and environmental factors, atopy (the propensity librium test may eliminate the possibility of false-positive results caused by differences in population stratification between cases to generate IgE in response to common environmental allergens) is by far the strongest risk factor for asthma that has been identiand control subjects (32). However, recruiting a sufficient number of father-mother-child trios is considerably more difficult, fied. In this study, adjusted odds ratios for atopy in the development of asthma were 4.47 (95% confidence interval, 2.90-6.89), particularly for late-onset disease. In addition, the case-control approach was recently successfully used to find common haplo-2.59 (1.84-3.48), and 1.62 (1.14-2.31) for early-, middle-and lateonset asthma, respectively. The Ϫ28G allele of the RANTES types that display significant population-attributable risk for non-insulin-dependent diabetes mellitus (33), thus indicating the promoter region was not associated with early-or middle-onset asthma; effects of this allele may be masked by the effects of usefulness of the case-control approach for study of adult-onset disease. Nevertheless, these findings are preliminary, and corrobother genetic risk factors related to atopy, including genes on chromosomes 5q31 (21) and 11q13 (22). Conversely, in patients orating evidence from an independent study with a more rigorous study design is required. with late-onset asthma (in whom genetic predisposition for atopy is generally less important as a risk factor), the genetic influence Case-control studies based on questionnaires are susceptible to recall bias. Definitions of physician-diagnosed asthma have of the Ϫ28G allele was evident.
In general, Th2-derived cytokines modulate expression of been shown to be specific but somewhat lacking in sensitivity; they probably exclude milder cases of asthma (34). In this study, chemokines in airway epithelia (23) and play a crucial role in the development of airway inflammation in asthma (24). In reto judge age at onset of asthma as accurately as possible, patients were asked about episodes of dyspnea, wheezing, or coughing sponse to interleukin-9 (a Th2 cytokine), human bronchial epithelial cells released RANTES in a dose-dependent fashion (25).
during childhood and puberty. In cases of uncertainty, the time of earliest respiratory symptoms was designated as the age at However, it should not be assumed that asthmatic inflammation is only induced by Th2 cytokines. This issue has recently been onset of asthma symptoms, which was used for the calculation of the duration of asthma. A recent study of age at onset of examined using experimental models in which investigators cotransferred Th1-and Th2-type specific lymphocytes into a naive asthma in 4,335 Japanese adult patients with asthmas found that 26.3% developed the disease before the age of 20 years, and mouse. They found that the presence of Th1-type cells did not suppress development of pulmonary disease but rather intensi-73.8% developed the disease at 20 years or older (35) . This variation in age at onset of adult asthma is very similar to that found fied the inflammation and exacerbated the lung pathophysiology (26) . These data, together with the fact that viral respiratory in this study ( Figure E1 in the online data supplement) and is evidence that the self-reported data on age at onset of asthma infections remain the leading trigger of asthma attacks, suggest a role for Th1 cells in pathophysiology of airway inflammation obtained in this study is reliable. However, we must point out that it is virtually impossible to distinguish recrudescent asthma in asthma. RANTES is induced by interferon-␥ and appears to be closely associated with Th1 response (27) . In addition, although cases from incident asthma cases in an adult population with any certainty. It seems unlikely that the Ϫ28C/G polymorphism increased production of RANTES within the bronchial mucosa is found in all cases of bronchial asthma, regardless of atopic contributed to this recall bias, even though a number of patients with asthma who we designated as late-onset may have develstatus, production levels tend to be greater in nonatopic asthmatics than in atopic asthmatics (3, 28) . Thus, increased expression oped the disease in their childhood. Therefore, we believe that the differences we observed in frequency of the Ϫ28G allele among of RANTES, especially in patients with late-onset nonatopic asthma, may reflect interferon-␥ production in response to varithe asthma subgroups cannot be attributed to the recall bias. In summary, it has previously been suggested that RANTES ous stimuli, including viral infections, or (perhaps more likely)
